Sales rep cuts in France, LEEM offers help

22 December 2008

Between 5,000 and 6,000 pharmaceutical sales representatives jobs are likely to be lost in France by 2010, according to the research-based drugmakers' group, the LEEM. The anticipated restructuring would involve a head count reduction of one in five, the group said.

Pascal Le Guyader, the LEEM's director of social affairs and employment, announced the launch of a web site (www.evolutionvm.org) to help drugmakers' marketing staff reposition themselves in the job market. He told the financial daily newspaper, Les Echos: "there will remain about 17,000 sales reps," with substantial changes to working practices to make it more of a knowledge-based and future-oriented activity. Mr Le Guyader noted that a "total suppression" of physician visits is not on the cards: "we are returning to the ratios of the years 1990-1995," he said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight